C. Canavan

1.4k total citations · 1 hit paper
15 papers, 1.1k citations indexed

About

C. Canavan is a scholar working on Epidemiology, Surgery and Genetics. According to data from OpenAlex, C. Canavan has authored 15 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 5 papers in Surgery and 5 papers in Genetics. Recurrent topics in C. Canavan's work include Inflammatory Bowel Disease (5 papers), Microscopic Colitis (5 papers) and Eosinophilic Esophagitis (3 papers). C. Canavan is often cited by papers focused on Inflammatory Bowel Disease (5 papers), Microscopic Colitis (5 papers) and Eosinophilic Esophagitis (3 papers). C. Canavan collaborates with scholars based in United Kingdom, United States and Ireland. C. Canavan's co-authors include J F Mayberry, Keith R. Abrams, Joe West, Tim Card, Douglas A. Drossman, Kay‐Tee Khaw, Richard F. Logan, J Eisenburg, Kathleen E. Corey and Lingyu Meng and has published in prestigious journals such as Blood, Gut and Heart.

In The Last Decade

C. Canavan

13 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Review article: the economic impact of the irritable bowel syndrome

2014 351 citations C. Canavan, Joe West et al. Alimentary Pharmacology & Therapeutics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C. Canavan United Kingdom	9	447	397	390	327	173	15	1.1k
Arun Swaminath United States	16	667 1.5×	532 1.3×	159 0.4×	475 1.5×	74 0.4×	82	1.3k
Jan A. J. M. Taminiau Netherlands	20	316 0.7×	219 0.6×	694 1.8×	787 2.4×	78 0.5×	44	1.5k
Karen Lasch United States	17	842 1.9×	660 1.7×	397 1.0×	554 1.7×	49 0.3×	74	1.5k
Christopher J. Justinich United States	20	419 0.9×	296 0.7×	340 0.9×	566 1.7×	48 0.3×	35	1.2k
Bobby Lo Denmark	16	408 0.9×	347 0.9×	228 0.6×	232 0.7×	54 0.3×	39	819
Tibor Hlavatý Slovakia	17	702 1.6×	652 1.6×	122 0.3×	331 1.0×	120 0.7×	58	1.3k
Albert Villòria Spain	21	403 0.9×	323 0.8×	589 1.5×	649 2.0×	34 0.2×	55	1.3k
Magnus Ström Sweden	21	1.5k 3.3×	1.6k 4.0×	521 1.3×	640 2.0×	105 0.6×	46	2.3k
Mariam Aguas Spain	19	717 1.6×	480 1.2×	134 0.3×	375 1.1×	93 0.5×	62	1.1k
Jan E. Irvine Canada	6	1.1k 2.6×	877 2.2×	229 0.6×	517 1.6×	55 0.3×	9	1.4k

Countries citing papers authored by C. Canavan

Since Specialization

Citations

This map shows the geographic impact of C. Canavan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Canavan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Canavan more than expected).

Fields of papers citing papers by C. Canavan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Canavan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Canavan. The network helps show where C. Canavan may publish in the future.

Co-authorship network of co-authors of C. Canavan

This figure shows the co-authorship network connecting the top 25 collaborators of C. Canavan. A scholar is included among the top collaborators of C. Canavan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Canavan. C. Canavan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

1.

Canavan, C., Thomas G. Knight, Nilay Shah, et al.. (2024). Oral Azacitidine Maintenance Therapy in Acute Myeloid Leukemia after Frontline Hypomethylating Agent and Venetoclax. Blood. 144(Supplement 1). 6036–6036.

2.

Nasim, Sana, et al.. (2019). Laboratory-confirmed metformin-associated lactic acidosis. University of Limerick Institutional Repository (University of Limerick). 112(8). 992–992. 2 indexed citations

3.

Varghese, Lijoy, et al.. (2016). The Public Health Perspective Of An Investigational Herpes Zoster Vaccine In The United Kingdom (Uk). Value in Health. 19(7). A400–A400. 4 indexed citations

4.

Canavan, C., Joe West, & Tim Card. (2014). Review article: the economic impact of the irritable bowel syndrome. Alimentary Pharmacology & Therapeutics. 40(9). 1023–1034. 351 indexed citations breakdown →

5.

Canavan, C., J Eisenburg, Lingyu Meng, Kathleen E. Corey, & Chin Hur. (2013). Ultrasound Elastography for Fibrosis Surveillance Is Cost Effective in Patients with Chronic Hepatitis C Virus in the UK. Digestive Diseases and Sciences. 58(9). 2691–2704. 23 indexed citations

6.

Canavan, C., Kathleen E. Corey, & Chin Hur. (2013). OC-081 Defining Cirrhosis with Fibroscan for entry to Hepatocellular Carcinoma Surveillance in Chronic Hepatitis C: a UK Cost Effectiveness Analysis. Gut. 62(Suppl 1). A35.1–A35. 1 indexed citations

7.

Canavan, C., Richard F. Logan, Kay‐Tee Khaw, & Joe West. (2011). No difference in mortality in undetected coeliac disease compared with the general population: a UK cohort study. Alimentary Pharmacology & Therapeutics. 34(8). 1012–1019. 36 indexed citations

8.

Canavan, C., Keith R. Abrams, & J F Mayberry. (2007). Meta‐analysis: mortality in Crohn’s disease. Alimentary Pharmacology & Therapeutics. 25(8). 861–870. 101 indexed citations

9.

Canavan, C., Keith R. Abrams, & J F Mayberry. (2006). Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease.. Leicester Research Archive (University of Leicester). 1 indexed citations

10.

Canavan, C., et al.. (2006). Long‐term prognosis in Crohn's disease: factors that affect quality of life. Alimentary Pharmacology & Therapeutics. 23(3). 377–385. 65 indexed citations

11.

Canavan, C., Keith R. Abrams, & J F Mayberry. (2006). Meta‐analysis: colorectal and small bowel cancer risk in patients with Crohn's disease. Alimentary Pharmacology & Therapeutics. 23(8). 1097–1104. 426 indexed citations

12.

Canavan, C., et al.. (2006). Long‐term prognosis in Crohn's disease: an epidemiological study of patients diagnosed more than 20 years ago in Cardiff. Alimentary Pharmacology & Therapeutics. 25(1). 59–65. 26 indexed citations

13.

Kee, Frank, et al.. (1995). Expanding access to coronary artery bypass surgery: who stands to gain?. Heart. 73(2). 129–133. 5 indexed citations

14.

Kee, Frank, et al.. (1994). Is choice of general practitioner important for patients having coronary artery investigations?. BMJ Quality & Safety. 3(1). 17–22. 9 indexed citations

15.

Herman, R., R. Scott Heller, C. Canavan, & Ceil A. Herman. (1988). Leukotriene C₄ action and metabolism in the isolated perfused bullfrog heart. Canadian Journal of Physiology and Pharmacology. 66(7). 980–984. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact